AAN.com
Quick search in Citations
AnywhereCitation
Advanced Search
Trending Terms:
Practice Across Borders
December 9, 2013

Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease
ITALY

Alberto Albanese, MDAuthors Info & Affiliations
December 2013 issue
3 (6) 476-477
https://doi.org/10.1212/01.CPJ.0000437018.37541.eb
Letters to the Editor
Track CitationsAdd to favorites
Get Access

Abstract

The diagnosis of Parkinson disease (PD) is for the most part made by neurologists. A survey performed by an Italian patient association estimated that in Italy about 20% of patients with PD ask for a medical consultation 2 years after onset of symptoms. The delay from first consultation (usually with a general practitioner) to diagnosis is around 5–6 months. Up to 80% of patients are referred to a center specialized in movement disorders, either early in the disease course or later, when motor complications appear. PD is for the most part treated by neurologists and there is insufficient exchange of information between the treating neurologist and the patient's general practitioner.

Get full access to this article

View all available purchase options and get full access to this article.

Get Access

Reference

1.
Quattrone A, Zappia M. Oral pulse levodopa therapy in mild Parkinson's disease. Neurology 1993;43:1161–1166.
Crossref
PubMed
Google Scholar

Information & Authors

Information

Published In

Neurology® Clinical Practice
Volume 3 • Number 6 • December 2013
Pages: 476-477

Copyright

© 2013 American Academy of Neurology.

Publication History

Published in print: December 2013
Published online: December 9, 2013

Permissions

Request permissions for this article.

Funding Information

Study funding: No targeted funding reported.Disclosures: A. Albanese serves as an Associate Editor for the European Journal of Neurology and as Editor-in-Chief of Frontiers in Movement Disorders; has received speaker honoraria from TEVA, Merz, Ipsen, and Medtronic; receives publishing royalties for Botulinum Toxin: Clinical Practice and Science (Saunders Elsevier, 2009); and has research support from Allergan, the Italian Ministry of Health, the Italian Ministry of Research, Catholic University, Beneficientia Stiftung, and the James and Gloria Grossweiler Foundation. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Authors

Affiliations & Disclosures

Alberto Albanese, MD
Istituto di Neurologia, Università Cattolica del Sacro Cuore, Rome, and Fondazione Istituto Neurologico Carlo Besta, Milan, Italy:
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
SpeakerÏ¿½s honoraria from TEVA, Merz, Ipsen and Medtronic
Editorial Boards:
1.
(1) European Journal of Neurology, Associate Editor, current; (2) Therapeutic Advances in Neurology, Associate Editor, ended 2011; (3) Frontiers in Movement Disorders, Editor, current
Patents:
1.
NONE
Publishing Royalties:
1.
(1) Botulinum Toxin: Clinical Practice and Science, Saunders Elsevier, 2009
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Allergan
Research Support, Government Entities:
1.
(1) Italian Ministry of Health, PI and non-PI, 2009-2010;(2) Italian Ministry of Research, PI, 2009
Research Support, Academic Entities:
1.
(1) Catholic University
Research Support, Foundations and Societies:
1.
Beneficientia StiftungJames and Gloria Grossweiler Foundation
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author

Notes

Correspondence to: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
    • Luis Sigcha,
    • Luigi Borzì,
    • Federica Amato,
    • Irene Rechichi,
    • Carlos Ramos-Romero,
    • Andrés Cárdenas,
    • Luis Gascó,
    • Gabriella Olmo,
    Deep learning and wearable sensors for the diagnosis and monitoring of Parkinson’s disease: A systematic review, Expert Systems with Applications, 229, (120541), (2023).https://doi.org/10.1016/j.eswa.2023.120541
    Crossref
    • Daniel Rodríguez-Martín,
    • Joan Cabestany,
    • Carlos Pérez-López,
    • Marti Pie,
    • Joan Calvet,
    • Albert Samà,
    • Chiara Capra,
    • Andreu Català,
    • Alejandro Rodríguez-Molinero,
    A New Paradigm in Parkinson's Disease Evaluation With Wearable Medical Devices: A Review of STAT-ONTM, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.912343
    Crossref

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share

View full text|Download PDF